SKIN RADIATION-RELATED ANGIOSARCOMA

Clinical trials for SKIN RADIATION-RELATED ANGIOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new SKIN RADIATION-RELATED ANGIOSARCOMA trials appear

Sign up with your email to follow new studies for SKIN RADIATION-RELATED ANGIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapies target Tough-to-Treat angiosarcoma

Disease control Ongoing

This study is testing two different drug combinations for adults with angiosarcoma, a rare and aggressive cancer. For patients who haven't had a specific type of chemo, it compares standard chemo (paclitaxel) alone to that chemo plus an immunotherapy drug (nivolumab). For patient…

Matched conditions: SKIN RADIATION-RELATED ANGIOSARCOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

SKIN RADIATION-RELATED ANGIOSARCOMA

Get alerted when new SKIN RADIATION-RELATED ANGIOSARCOMA trials appear

New combo therapies target Tough-to-Treat angiosarcoma